Plain-English translation of NCT07129811 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a procedure called stellate ganglion block — an injection that calms overactive nerves in the upper arm — combined with physical therapy for stroke patients who develop severe, long-lasting pain and stiffness. About half of the participants will receive the nerve block injection plus 10 sessions of physical therapy, while the other half will receive physical therapy alone. Researchers will measure pain levels, arm function, and quality of life at several time points to see if this treatment combination works better than therapy by itself.
Many stroke survivors develop a painful condition in their weakened arm that makes recovery harder and reduces their quality of life. While physical therapy is standard treatment, some patients still struggle with pain that gets in the way of regaining arm strength and independence. This trial wants to find out whether adding this nerve-blocking injection might break the cycle of pain and help patients recover better.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll come to the hospital for an initial evaluation, then be randomly assigned to one of two groups. One group will receive a nerve block injection (a single procedure) plus 10 sessions of physical therapy and exercise over several weeks; the other group will do physical therapy and exercise alone. You'll complete follow-up assessments at 2 weeks and 12 weeks after your therapy sessions end, answering questions about your pain, arm strength, and how the condition affects your daily life.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Turkey (Türkiye)
Sponsor
Ankara City Hospital Bilkent
Enrollment target
~32 participants
Started
January 2025
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Seher KALIÇ MD
Ankara City Hospital Bilkent
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.